MNOV MediciNova, Inc. - Common Stock
$1,33
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 13, 2026
52 Haftlık Aralık
$1–$2
20% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$9
+577% upside
P/E (TTM)
-5.5
ROE
-27.1%
Net Kâr Marjı
-2928.8%
MNOV Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.33
Piyasa Değeri
$65M
P/E (TTM)
-5.5
EPS (TTM)
$-0.24
Gelir (TTM)
$409.7K
Temettü Verimi
—
ROE
-27.1%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $2
MNOV Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$409.7K
2021-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.24
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-10M
2016-12-31
→
2025-12-31
Marjlar
-2928.8%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
MNOV
Akran Ortalaması
P/E (TTM)
-5.5
—
P/S (TTM) (F/S (TTM))
159.8
165.8
P/B (F/D)
1.6
1.6
Price / FCF (Fiyat / Serbest Nakit Akışı)
-6.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
MNOV
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-3242.5%
—
Net Profit Margin (Net Kâr Marjı)
-2928.8%
-2229.6%
ROA
-23.6%
-64.3%
ROE
-27.1%
-102.1%
ROIC
-32.0%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
MNOV
Akran Ortalaması
Current Ratio (Cari Oran)
8.2
4.8
Quick Ratio (Cari Oran)
8.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
MNOV
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
MNOV
Akran Ortalaması
MNOV Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 2 22,2%
- Al 6 66,7%
- Tut 1 11,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
3 analist · 2026-08-16
Medyan
$10.00
Ortalama
$9.00
← Tüm hedeflerin altında
$1.33
Düşük
$6.00
Yüksek
$11.00
Medyan hedef
$10.00
+651,9%
Ortalama hedef
$9.00
+576,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.04%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.05 | $-0.07 | 0.02% |
| 31 Aralık 2025 | $-0.05 | $-0.10 | 0.05% |
| 30 Eylül 2025 | $-0.06 | $-0.10 | 0.04% |
| 30 Haziran 2025 | $-0.07 | $-0.10 | 0.03% |
| 31 Mart 2025 | $-0.06 | $-0.14 | 0.08% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
| XBIT | — | -1.6 | — | — | — | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $409.7K | · | $1M | · | $4M | · | · | · | · | · | · | · | |
| R&D Expense | $7M | $7M | $5M | $9M | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $3M | |
| SG&A Expense | $6M | $5M | $5M | $5M | $6M | $7M | $8M | $10M | $9M | $7M | $6M | $6M | |
| Operating Expenses | $14M | $13M | $11M | $15M | $14M | $14M | $14M | $16M | $13M | $11M | $9M | $9M | |
| Operating Income | $-13M | $-13M | $-10M | $-15M | $-10M | $-14M | $-14M | $-16M | $-13M | $-11M | $-9M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $298 | $454 | $514 | $628 | |
| Other Non-op | $-12.8K | $-39.5K | $-502.9K | $-247.3K | $-59.5K | $-38.4K | $-46.2K | $-22.9K | $-25.6K | $-47.0K | · | · | |
| Pretax Income | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-13M | $-11M | $-9M | $-9M | |
| Income Tax | $6.0K | $5.5K | $3.0K | $2.8K | $2.6K | $-1.6K | $12.7K | $5.3K | $-2M | $3.8K | $7.4K | $-4.0K | |
| Net Income | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-11M | $-11M | $-9M | $-9M | |
| EPS (Basic) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 49,063,438 | 49,046,246 | 49,046,246 | 49,045,342 | 48,596,255 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 49,063,438 | 49,046,246 | 49,046,246 | 49,045,342 | 48,596,255 | · | · | · | · | · | · | · | |
| EBITDA | $-13M | $-13M | $-10M | $-15M | $-10M | $-14M | $-14M | $-16M | $-13M | $-11M | $-9M | $-9M |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31M | $40M | $51M | $19M | $71M | $60M | $64M | $62M | $28M | $24M | $22M | $12M | |
| Short-term Investments | · | · | · | $40M | · | · | · | · | · | · | · | · | |
| Receivables | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $184.8K | $714.5K | $174.9K | $499.4K | $578.0K | $680.2K | $511.9K | $444.9K | $336.6K | $585.8K | $649.5K | $463.5K | |
| Current Assets | $31M | $41M | $51M | $59M | $72M | $61M | $64M | $63M | $28M | $25M | $23M | $12M | |
| PP&E (Net) | $8.3K | $25.5K | $45.8K | $45.3K | $57.6K | $55.7K | $40.5K | $53.1K | $62.9K | $90.7K | $20.4K | $44.8K | |
| PP&E (Gross) | $431.1K | $428.2K | $489.3K | $478.1K | $482.8K | $579.3K | $538.4K | $536.7K | $534.6K | $590.1K | $503.7K | $506.8K | |
| Accum. Depreciation | $422.8K | $402.7K | $443.5K | $432.8K | $425.2K | $523.6K | $497.9K | $483.5K | $471.7K | $499.4K | $483.2K | $461.9K | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Other Non-current Assets | $19.0K | $19.0K | $74.2K | $92.8K | $115.5K | $75.4K | $459.8K | $11.0K | $11.0K | · | $109.0K | $10.7K | |
| Total Assets | $46M | $56M | $66M | $74M | $87M | $75M | $79M | $77M | $43M | $40M | $38M | $27M | |
| Accounts Payable | $625.0K | $1M | $1M | $424.6K | $402.7K | $616.6K | $451.3K | $616.8K | $2M | $367.3K | $170.8K | $462.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | $2M | $1M | $1M | $1M | $1M | |
| Current Liabilities | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | |
| Capital Leases | $17.1K | $211.5K | $410.7K | $523.6K | $694.7K | $2.7K | $182.6K | · | · | · | · | · | |
| Deferred Tax | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $2M | $2M | $2M | |
| Other Non-current Liabilities | $17.1K | $211.5K | $410.7K | $523.6K | $694.7K | $2.7K | $186.4K | $27.2K | · | · | · | · | |
| Total Liabilities | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Common Stock | $49.2K | $49.0K | $49.0K | $49.0K | $49.0K | $45.0K | $43.9K | $42.1K | $36.5K | $34.5K | $30.0K | $24.4K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $365M | $352M | $333M | |
| Retained Earnings | $-439M | $-427M | $-416M | $-407M | $-393M | $-383M | $-369M | $-356M | $-341M | $-330M | $-319M | $-311M | |
| AOCI | $-127.2K | $-135.2K | $-118.1K | $-115.3K | $-98.9K | $-88.2K | $-92.7K | $-93.2K | $-94.6K | $-96.0K | $-102.8K | $-101.0K | |
| Stockholders' Equity | $42M | $53M | $62M | $70M | $84M | $71M | $75M | $73M | $39M | $35M | $33M | $22M | |
| Liabilities + Equity | $46M | $56M | $66M | $74M | $87M | $75M | $79M | $77M | $43M | $40M | $38M | $27M | |
| Shares Outstanding | 49,221,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,043,246 | 45,024,560 | 43,908,065 | 42,081,306 | 36,452,893 | 34,523,678 | 29,956,495 | 24,436,317 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.1K | $21.1K | $20.3K | $17.7K | $26.1K | $21.3K | $23.9K | $25.9K | $28.1K | $14.1K | $26.7K | $40.2K | |
| Stock-based Comp | $829.1K | $1M | $710.7K | $642.5K | $2M | $3M | $4M | $6M | $4M | $4M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $-2M | · | · | $0 | |
| Other Non-cash | $1M | $-806.2K | $409.5K | $497.3K | $-991.0K | $-169.4K | $-319.9K | $-795.2K | $1M | $333.1K | $-359.5K | $8M | |
| Operating Cash Flow | $-10M | $-11M | $-7M | $-13M | $-9M | $-11M | $-9M | $-9M | $-7M | $-7M | $-7M | $816.5K | |
| CapEx | $2.9K | $895 | $21.3K | $5.0K | $28.7K | $36.5K | $11.3K | $10.2K | · | $84.5K | $2.3K | $3.5K | |
| Investing Cash Flow | $-2.9K | $-697 | $40M | $-40M | $-28.7K | $-36.5K | $-11.3K | $626.3K | · | $-84.5K | · | · | |
| Stock Issued | $244.0K | $0 | · | · | · | · | · | · | · | · | $17M | $4M | |
| Net Stock Activity | $244.0K | · | · | · | · | · | · | · | · | · | $17M | · | |
| Financing Cash Flow | $244.0K | $0 | · | $7.9K | $21M | $7M | $11M | $43M | $11M | $9M | · | · | |
| Net Change in Cash | $-10M | $-11M | $32M | $-53M | $11M | $-4M | $1M | $34M | $4M | $2M | $10M | $5M | |
| Taxes Paid | $6.0K | $5.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $-11M | $-7M | $-13M | $-9M | $-11M | $-9M | $-9M | · | $-7M | $-7M | $813.0K | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-7M | $-7M | $812.4K |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3242.5% | · | -990.0% | · | -253.0% | · | · | · | · | · | · | · | |
| Net Margin | -2928.8% | · | -857.2% | · | -251.0% | · | · | · | · | · | · | · | |
| Pretax Margin | -2927.3% | · | -856.9% | · | -250.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -3237.6% | · | -988.0% | · | -252.4% | · | · | · | · | · | · | · | |
| ROA | -23.6% | -18.1% | -12.2% | -17.4% | -12.4% | -17.9% | -16.6% | -24.3% | -26.8% | -28.0% | -27.1% | -32.4% | |
| ROE | -27.1% | -20.5% | -13.5% | -19.6% | -11.9% | -19.1% | -17.3% | -20.0% | -30.5% | -32.3% | -32.3% | -38.8% | |
| ROIC | -32.0% | -24.1% | -15.9% | -20.8% | -12.2% | -19.9% | -18.8% | -21.3% | -29.2% | -31.5% | -27.0% | -41.9% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | 13.9 | 15.6 | 18.5 | 25.4 | 27.7 | 28.9 | 28.6 | 9.8 | 15.2 | 15.2 | 7.6 | |
| Quick Ratio | 8.1 | 13.6 | 15.6 | 18.3 | 25.2 | 27.4 | 28.6 | 28.4 | 9.7 | 14.8 | 14.8 | 7.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -43715.1 | -23968.8 | -17164.2 | -14686.3 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | 0.0 | · | · | · | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $409.7K | · | $1M | · | $4M | · | · | · | · | · | · | · | |
| Net Income TTM | $-12M | $-11M | $-9M | $-14M | $-10M | $-14M | $-13M | $-15M | $-11M | $-11M | $-9M | $-9M | |
| Market Cap | $64M | $103M | $74M | $101M | $131M | $237M | $296M | $344M | $236M | $208M | $106M | $74M | |
| P/E | -5.5 | -9.1 | -8.8 | -7.1 | -12.8 | -21.9 | -28.1 | -34.0 | -27.0 | -25.1 | -14.8 | -12.7 | |
| P/S | 157.4 | · | 73.6 | · | 32.6 | · | · | · | · | · | · | · | |
| P/B | 1.6 | 2.0 | 1.2 | 1.4 | 1.6 | 3.3 | 4.0 | 4.7 | 6.1 | 6.0 | 3.2 | 3.4 | |
| P / Tangible Book | 2.0 | 2.4 | 1.4 | 1.7 | 1.8 | 3.8 | · | · | · | · | · | · | |
| P / Cash Flow | -6.6 | -9.7 | -9.9 | -7.8 | -14.0 | -21.9 | -32.4 | -37.7 | -34.1 | -31.8 | -14.9 | 91.0 | |
| P / FCF | -6.6 | -9.7 | -9.9 | -7.8 | -14.0 | -21.8 | -32.4 | -37.7 | · | -31.4 | -14.9 | 91.4 | |
| Earnings Yield | -18.3% | -10.9% | -11.3% | -14.1% | -7.8% | -4.6% | -3.6% | -2.9% | -3.7% | -4.0% | -6.8% | -7.9% |
Gelir Tablosu 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $458.4K | $187.0K | $151.7K | $123.3K | $134.6K | · | · | · | · | · | $0 | $1M | · | · | · | · | |
| R&D Expense | $900.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $700.0K | $2M | $1M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $839.3K | $1M | $2M | $1M | $1M | $1M | |
| Operating Expenses | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $4M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-1M | $-3M | $-3M | $-3M | $-4M | |
| Other Non-op | $-4.9K | $-3.4K | $-5.8K | $-10.2K | $952 | $2.3K | $-15.5K | $9.1K | $-17.1K | $-16.0K | $-2.2K | $-14.2K | $-23.2K | $-463.3K | $-194.7K | $-8.5K | |
| Net Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-723.1K | $-3M | $-3M | $-3M | $-4M | |
| EPS (Basic) | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.06 | $-0.04 | $-0.01 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.06 | $-0.04 | $-0.01 | $-0.06 | $-0.06 | $-0.07 | $-0.07 | |
| Shares (Basic) | 49,221,246 | 49,221,246 | -98,075,300 | 49,046,246 | 49,046,246 | 49,046,246 | -98,092,492 | 49,046,246 | 49,046,246 | 49,046,246 | -98,092,492 | 49,046,246 | 49,046,246 | 49,046,246 | -98,089,737 | 49,046,246 | |
| Shares (Diluted) | 49,221,246 | 49,221,246 | -98,075,300 | 49,046,246 | 49,046,246 | 49,046,246 | -98,092,492 | 49,046,246 | 49,046,246 | 49,046,246 | -98,092,492 | 49,046,246 | 49,046,246 | 49,046,246 | -98,089,737 | 49,046,246 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-3M | · | $-3M | $-3M | $-3M | · | $-1M | $-3M | $-3M | · | $-4M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $31M | $33M | $34M | $37M | $40M | $42M | $44M | $47M | $51M | $52M | $53M | $55M | $19M | $53M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $40M | · | |
| Receivables | $0 | $245.1K | · | $0 | $134.6K | · | · | · | · | · | · | $1M | · | · | · | · | |
| Prepaid Expense | $505.5K | $571.5K | $184.8K | $359.9K | $729.6K | $1M | $714.5K | $984.9K | $1M | $724.8K | $174.9K | $488.8K | $645.5K | $775.0K | $499.4K | $641.7K | |
| Current Assets | $26M | $28M | $31M | $33M | $35M | $38M | $41M | $43M | $46M | $48M | $51M | $53M | $54M | $56M | $59M | $53M | |
| PP&E (Net) | $9.8K | $14.9K | $8.3K | $12.9K | $15.4K | $20.4K | $25.5K | $30.8K | $35.8K | $40.4K | $45.8K | $51.2K | $54.6K | $41.1K | $45.3K | $45.9K | |
| PP&E (Gross) | · | · | $431.1K | · | · | · | $428.2K | · | · | · | $489.3K | · | · | · | $478.1K | · | |
| Accum. Depreciation | · | · | $422.8K | · | · | · | $402.7K | · | · | · | $443.5K | · | · | · | $432.8K | · | |
| Goodwill | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Other Non-current Assets | $0 | $0 | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $70.4K | $74.2K | $71.1K | $72.8K | $77.5K | $92.8K | $101.7K | |
| Total Assets | $40M | $43M | $46M | $48M | $50M | $52M | $56M | $58M | $60M | $63M | $66M | $68M | $69M | $71M | $74M | $78M | |
| Accounts Payable | $950.5K | $852.4K | $625.0K | $746.0K | $569.4K | $718.9K | $1M | $708.2K | $667.7K | $804.8K | $1M | $736.9K | $548.2K | $585.1K | $424.6K | $552.7K | |
| Current Liabilities | $3M | $3M | $4M | $3M | $3M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | |
| Capital Leases | $0 | $0 | $17.1K | $74.4K | $117.0K | $165.2K | $211.5K | $255.2K | $302.5K | $351.2K | $410.7K | $463.8K | $519.7K | $489.4K | $523.6K | $555.8K | |
| Deferred Tax | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | $201.8K | |
| Other Non-current Liabilities | $0 | $0 | $17.1K | $74.4K | $117.0K | $165.2K | $211.5K | $255.2K | $302.5K | $351.2K | $410.7K | $463.8K | $519.7K | $489.4K | $523.6K | $555.8K | |
| Total Liabilities | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | $4M | $5M | |
| Common Stock | $49.2K | $49.2K | $49.2K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | $49.0K | |
| Retained Earnings | $-444M | $-441M | $-439M | $-436M | $-433M | $-430M | $-427M | $-424M | $-421M | $-418M | $-416M | $-414M | $-413M | $-410M | $-407M | $-404M | |
| AOCI | $-127.4K | $-128.1K | $-127.2K | $-126.8K | $-127.4K | $-130.1K | $-135.2K | $-123.8K | $-131.5K | $-127.0K | $-118.1K | $-123.8K | $-121.0K | $-116.8K | $-115.3K | $-124.3K | |
| Stockholders' Equity | $37M | $39M | $42M | $44M | $47M | $50M | $53M | $55M | $57M | $60M | $62M | $65M | $65M | $68M | $70M | $73M | |
| Liabilities + Equity | $40M | $43M | $46M | $48M | $50M | $52M | $56M | $58M | $60M | $63M | $66M | $68M | $69M | $71M | $74M | $78M | |
| Shares Outstanding | 49,221,246 | 49,221,246 | 49,221,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 | 49,046,246 |
Nakit Akışı 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5.0K | $4.3K | $4.6K | $5.3K | $5.1K | $5.2K | $5.2K | $5.2K | $5.4K | $5.3K | $5.5K | $5.7K | $5.0K | $4.1K | $4.3K | $4.5K | |
| Stock-based Comp | $176.8K | $407.8K | $180.6K | $157.7K | $204.9K | $285.9K | $264.0K | $504.9K | $207.5K | $215.4K | $-237.4K | $219.1K | $325.7K | $403.3K | $128.7K | $158.3K | |
| Other Non-cash | · | $-1M | · | · | · | $-1M | · | · | · | $-1M | · | · | · | $-667.3K | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-4M | $-499.1K | $-1M | $-2M | $-3M | $-4M | $-3M | |
| CapEx | $0 | $10.8K | $0 | $2.9K | $0 | $0 | $-2 | $6 | · | · | $-22 | $2.7K | · | · | · | · | |
| Investing Cash Flow | $0 | $-10.8K | $0 | $-2.9K | $0 | $0 | $1 | $193 | · | · | $22 | $-2.7K | $-18.6K | $40M | $-30M | · | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Net Change in Cash | $-2M | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-4M | $-507.9K | $-1M | $-2M | $37M | $-34M | $-13M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Kârlılık 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -554.3% | -1516.6% | · | -2741.7% | -2679.9% | · | · | · | · | · | · | -114.7% | · | · | · | · | |
| Net Margin | -504.8% | -1383.1% | · | -2473.6% | -2437.8% | · | · | · | · | · | · | -72.3% | · | · | · | · | |
| EBITDA Margin | -554.3% | -1514.3% | · | -2741.7% | -2679.9% | · | · | · | · | · | · | -114.7% | · | · | · | · | |
| ROA | -5.1% | -5.4% | · | -5.8% | -5.9% | -5.0% | · | -4.5% | -3.7% | -4.2% | · | -0.99% | · | -3.8% | · | -4.3% | |
| ROE | -5.5% | -5.8% | · | -6.2% | -6.3% | -5.2% | · | -4.8% | -3.9% | -4.4% | · | -1.1% | · | -3.9% | · | -4.6% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.8 | 9.1 | · | 9.9 | 13.3 | 17.7 | · | 16.7 | 18.2 | 19.1 | · | 18.9 | · | 20.6 | · | 11.7 | |
| Quick Ratio | 8.6 | 8.9 | · | 9.8 | 13.0 | 17.1 | · | 16.3 | 17.8 | 18.8 | · | 18.7 | · | 20.4 | · | 11.6 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | 6.8 | 0.1 | · | 0.2 | 2.0 | · | · | · | · | · | · | 2.0 | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $903.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-11M | $-12M | · | $-12M | $-12M | $-11M | · | $-9M | $-9M | $-9M | · | $-10M | $-13M | $-14M | · | $-15M | |
| Market Cap | $65M | $67M | · | $62M | $64M | $72M | · | $103M | $71M | $71M | · | $103M | · | $106M | · | $106M | |
| P/E | -5.7 | -5.7 | · | -5.1 | -5.5 | -6.3 | · | -11.7 | -8.0 | -7.6 | · | -10.4 | -8.5 | -7.7 | · | -7.5 | |
| P/S | 71.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.9 | 1.2 | 1.2 | · | 1.6 | · | 1.6 | · | 1.5 | |
| P / Tangible Book | 2.3 | 2.3 | · | 1.8 | 1.7 | 1.8 | · | 2.3 | 1.5 | 1.4 | · | 1.9 | · | 1.8 | · | 1.7 | |
| P / Cash Flow | · | -19.4 | · | · | · | -18.9 | · | · | · | -18.4 | · | · | · | -33.3 | · | · | |
| P / FCF | · | -19.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -17.4% | -17.5% | · | -19.7% | -18.3% | -15.8% | · | -8.6% | -12.5% | -13.1% | · | -9.6% | -11.7% | -13.0% | · | -13.4% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $409.7K | — | $1M | — | $4M |
| Faaliyet Kâr Marjı % | -3242.5% | — | -990.0% | — | -253.0% |
| Net Gelir | $-12M | $-11M | $-9M | $-14M | $-10M |
| Seyreltilmiş Hisse Başı Kâr | $-0.24 | $-0.23 | $-0.17 | $-0.29 | $-0.21 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 8.2 | 13.9 | 15.6 | 18.5 | 25.4 |
| Cari Oran | 8.1 | 13.6 | 15.6 | 18.3 | 25.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-10M | $-11M | $-7M | $-13M | $-9M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 31 dosya · $6.0M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (+4 önceki Ç'ye göre) | 4 (-1 önceki Ç'ye göre) | 4 (-2 önceki Ç'ye göre) | 7 (-2 önceki Ç'ye göre) | +609K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Essex Woodlands Management, Inc. | $1.459.842 | 1.105.941 | 24,30% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $803.949 | 609.052 | 13,38% | Hisse senetleri |
| VANGUARD GROUP INC | $621.921 | 474.749 | 10,35% | Hisse senetleri |
| CITIGROUP INC | $591.303 | 447.957 | 9,84% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $571.155 | 432.545 | 9,51% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $373.043 | 282.608 | 6,21% | Hisse senetleri |
| UBS Group AG | $293.304 | 222.200 | 4,88% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $271.128 | 205.400 | 4,51% | Hisse senetleri |
| STATE STREET CORP | $255.681 | 193.698 | 4,26% | Hisse senetleri |
| NORTHERN TRUST CORP | $189.638 | 143.665 | 3,16% | Hisse senetleri |
| Bank of New York Mellon Corp | $97.130 | 73.583 | 1,62% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $94.388 | 71.506 | 1,57% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $73.961 | 56.031 | 1,23% | Hisse senetleri |
| SBI Securities Co., Ltd. | $67.952 | 51.479 | 1,13% | Hisse senetleri |
| Schonfeld Strategic Advisors LLC | $47.726 | 36.157 | 0,79% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $35.538 | 26.923 | 0,59% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35.313 | 26.752 | 0,59% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $20.591 | 15.599 | 0,34% | Hisse senetleri |
| JANE STREET GROUP, LLC | $20.240 | 15.333 | 0,34% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $17.854 | 13.526 | 0,30% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $17.685 | 13.500 | 0,29% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $17.370 | 13.159 | 0,29% | Hisse senetleri |
| BlackRock, Inc. | $13.893 | 10.525 | 0,23% | Hisse senetleri |
| Focus Partners Advisor Solutions, LLC | $13.200 | 10.000 | 0,22% | Hisse senetleri |
| MORGAN STANLEY | $2.640 | 2.000 | 0,04% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $403 | 305 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $272 | 206 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $87 | 66 | 0,00% | Hisse senetleri |
| Larson Financial Group LLC | $7 | 5 | 0,00% | Hisse senetleri |
| HANTZ FINANCIAL SERVICES, INC. | $6 | 4.232 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $3 | 2 | 0,00% | Hisse senetleri |
Şirket yöneticileri 26 içeriden öğrenenler · 12 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Yuichi Iwaki | President and CEO | 07 Ocak 2016 A | 568.972 | 0 | 0 | $0 |
| Esther Van Den Boom | Chief Financial Officer | 07 Ağustos 2014 A | — | 0 | 0 | $0 |
| Shintaro Asako | Chief Financial Officer | 29 Ocak 2010 A | — | 0 | 0 | $0 |
| Geoffrey Obrien | Vice President | 05 Temmuz 2016 M | 5.000 | 0 | 0 | $0 |
| Kazuko Matsuda | Chief Medical Officer | 14 Mart 2016 X | 62.003 | 0 | 0 | $0 |
| Masatsune Okajima | VP and Head of Japanese Office | 14 Mart 2016 X | 51.138 | 0 | 0 | $0 |
| Michael Denis Coffee | Chief Business Officer | 13 Mayıs 2013 A | 4.000 | 0 | 0 | $0 |
| Kirk William Johnson | Chief Scientific Officer | 13 Mayıs 2013 A | 1.700 | 0 | 0 | $0 |
| Michael E Kalafer | Chief Medical Officer | 28 Temmuz 2009 X | 31.744 | 0 | 0 | $0 |
| Richard E Gammans SR | Chief Development Officer | 30 Ocak 2009 A | — | 0 | 0 | $0 |
| Kenneth W Locke | Chief Scientific Officer | 07 Ocak 2008 A | — | 0 | 0 | $0 |
| Joji Suzuji | Sr. V.P., Finance & Admin. | 04 Ocak 2006 A | — | 0 | 0 | $0 |
| Nicole Lemerond | Yönetim kurulu üyesi | 23 Haziran 2026 A | — | 0 | 0 | $0 |
| Carolyn Beaver | Yönetim kurulu üyesi | 23 Haziran 2026 A | — | 0 | 0 | $0 |
| Hideki Nagao | Yönetim kurulu üyesi | 23 Haziran 2026 A | — | 0 | 0 | $0 |
| Yoshio Ishizaka | Yönetim kurulu üyesi | 09 Haziran 2016 A | 5.000 | 0 | 0 | $0 |
| Yutaka Kobayashi | Yönetim kurulu üyesi | 09 Haziran 2016 A | 60.000 | 0 | 0 | $0 |
| Tatsuo Izumi | Yönetim kurulu üyesi | 12 Aralık 2013 S | 600.000 | 0 | 0 | $0 |
| Arlene Morris | Yönetim kurulu üyesi | 21 Mayıs 2013 M | 0 | 0 | 0 | $0 |
| David D O'Toole | Yönetim kurulu üyesi | 29 Mayıs 2012 P | 5.000 | 0 | 0 | $0 |
| Hiroaki Shigeta | Yönetim kurulu üyesi | 10 Mayıs 2012 M | 45.000 | 0 | 0 | $0 |
| John K A Prendergast | Yönetim kurulu üyesi | 18 Temmuz 2011 A | — | 0 | 0 | $0 |
| Jeff Himawan | Yönetim kurulu üyesi | 14 Haziran 2011 A | — | 0 | 0 | $0 |
| Alan W Dunton | Yönetim kurulu üyesi | 11 Haziran 2010 A | — | 0 | 0 | $0 |
| Daniel Vapnek | — | 09 Haziran 2008 A | — | 0 | 0 | $0 |
| Tanabe Holding America Inc. | — | 13 Ekim 2006 D | 5.000.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| 3D Investment Partners Pte. Ltd., 3D Opportunity Master Fund ×2 başvurular | 12 Temmuz 2022 | — | İlk başvuru | — | SEC |
| KISSEI PHARMACEUTICAL CO., LTD ×3 başvurular | 14 Haziran 2017 | — | İlk başvuru | — | SEC |
| Essex Woodlands Health Ventures Fund VI, L.P., Essex Woodlands Health Ventures VI, L.P., Essex Woodlands Health Ventures VI, L.L.C., James L. Currie, Martin P. Sutter, Immanuel Thangaraj, Jeff Himawan, Ph.D, Petri Vainio, MD, Ph.D. ×2 başvurular | 12 Şubat 2016 | — | İlk başvuru | — | SEC |
| Yuichi Iwaki | 28 Ocak 2011 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.